Recombinant SARS-CoV-2 Nucleocapsid antibody (AA 1-419)

Catalog No. ABIN6952664

The HEK-293 Cells Chimeric anti-SARS-CoV-2 Nucleocapsid antibody has been validated for ELISA, WB and GICA. It is suitable to detect SARS-CoV-2 Nucleocapsid in samples from SARS Coronavirus-2 (SARS-CoV-2). There is 1 publication available.

Quick Overview for Recombinant SARS-CoV-2 Nucleocapsid antibody (AA 1-419) (ABIN6952664)

Target: SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)

Antibody Type: Recombinant Antibody

Fragment: scFv fragment

Reactivity: SARS Coronavirus-2 (SARS-CoV-2)

Host: HEK-293 Cells

Clonality: Chimeric

Conjugate: This SARS-CoV-2 Nucleocapsid antibody is un-conjugated

Application: ELISA, Western Blotting (WB), Colloidal Gold Immunochromatography Assay (GICA)

Clone: 1A6

Product Details anti-SARS-CoV-2 Nucleocapsid Antibody

Binding Specificity: AA 1-419

Specificity: Mouse scFv fusion with human IgG1 Fc

Characteristics: Recombinant anti-SARS-CoV-2 Nucleoprotein Mouse ScFv is expressed from 293 cells (HEK293) with a human IgG1 Fc tag on C-terminal.

Purification: Affinity-chromatography

Immunogen: Recombinant Human Novel Coronavirus Nucleoprotein (N) (1-419aa)

Isotype: IgG1

Application Details

Application Notes: ELISA 1:10000-1:50000
WB 1:500-1:5000
GICA 1:1000-1:50000

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: 50 % Glycerol, 0.01M PBS, pH 7.4, 0.03 % Proclin 300

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C,-80 °C

Storage Comment: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

References for anti-SARS-CoV-2 Nucleocapsid antibody (ABIN6952664)

Rabdano, Ruzanova, Pletyukhina, Saveliev, Kryshen, Katelnikova, Beltyukov, Fakhretdinova, Safi, Rudakov, Arakelov, Andreev, Kofiadi, Khaitov, Valenta, Kryuchko, Berzin, Belozerova, Evtushenko, Truhin et al.: "Immunogenicity and In Vivo Protective Effects of Recombinant Nucleocapsid-Based SARS-CoV-2 Vaccine Convacell®. ..." in: Vaccines, Vol. 11, Issue 4, (2023) (PubMed).

Target Details for SARS-CoV-2 Nucleocapsid

Target: SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)

Alternative Name: SARS-CoV-2 Nucleocapsid Protein

Target Type: Viral Protein

UniProt: P0DTC9